Norman Payson

CIK 898544 · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.70M

Companies

5

Total Filings

128

Lifetime Open-Market Net

-$83.12M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PGNY Director 134,842 $26.63 $3.59M -$83.12M 119 2026-05-26
Apria, Inc. (APR) Delisted Director $37.50 $0 1 2022-03-29
EVH Director 21,284 $4.80 $102.2K $0 3 2018-06-15
IDENIX PHARMACEUTICALS INC (IDIX) Delisted Director $0 2 2008-06-04
AHG Director 3,000 $1.34 $4.0K $0 1 2007-05-07

Recent Filings · Page 8 of 13

128 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-03-19 PGNY Sell (S) −10,000 -$477.6K EDGAR
2021-03-12 PGNY Sell (S) −10,000 -$467.9K EDGAR
2021-03-05 PGNY Sell (S) −10,000 -$421.4K EDGAR
2021-02-26 PGNY Sell (S) −10,000 -$496.2K EDGAR
2021-02-19 PGNY Sell (S) −10,000 -$490.8K EDGAR
2021-02-12 PGNY Sell (S) −10,000 -$498.6K EDGAR
2021-02-05 PGNY Sell (S) −10,000 -$484.3K EDGAR
2021-01-29 PGNY Sell (S) −10,000 -$456.2K EDGAR
2021-01-22 PGNY Sell (S) −10,000 -$481.3K EDGAR
2021-01-15 PGNY Sell (S) −10,000 -$451.1K EDGAR
Showing 7180 of 128
Page 8 of 13
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.